Stanley Laman Group, Ltd. Halozyme Therapeutics, Inc. Transaction History

Stanley Laman Group, Ltd.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 08, 2022	SELL	$37.35 - $48.3 $2.36 Million - $3.05 Million	-63,196 Closed	0 $0
Q1 2022 Apr 21, 2022	SELL	$31.97 - $41.06 $104,318 - $133,978	-3,263 Reduced 4.91%	63,196 $2.52 Million
Q4 2021 Jan 25, 2022	BUY	$31.82 - $40.75 $2.11 Million - $2.71 Million	66,459 New	66,459 $2.67 Million

543

125M

294K

180K

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $6.62B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

Get notified when there are updates to the investment portfolio of Stanley Laman Group, Ltd., based on Form 13F filings with the SEC.

Stay updated on Stanley Laman Group, Ltd. with notifications on news.